CTS shares rose 9.8% after earnings, with investors responding to record margins and EPS alongside broad-based demand indicators. Revenue grew 5% year over year, while a 1.18 company book-to-bill and strong bookings in industrial and aerospace and defense point to continued demand; medical bookings were a notable weak spot.
CTS reported a modest 1.9% stock increase following Q2 earnings, reflecting solid revenue growth and margin expansion balanced against modest transportation declines and cautious near-term segment performances.
Shares of CTS Corporation rose 5.2% following first quarter results that reflected notable upside in top-line growth and significant margin expansion. Outperformance in diversified end markets, especially medical and industrial, along with a 250bps increase in gross margin, resonated positively with investors.